Tarsus Pharmaceuticals, Inc. (TARS) Insider Trading

Name: Tarsus Pharmaceuticals, Inc. (TARS) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 17, 2026): PYOTT DAVID E I (Director): Exercise/Conversion of 201 shares.

Get alerted when insiders trade TARS

Email address

Loading company data...

Beta

Loading company details...

Beta